latanoprost  - Drug Details
📊 Estimates latanoprost  Dialyzability By Different_Modalities

latanoprost 

Complete Drug Information

Drug Name
latanoprost 
Trade Names
Xalatan
Pregnancy Category
AU: B3
Routes of Administration
Topical eye drop
Metabolism
Activation by ester hydrolysis, deactivation by beta oxidation
Elimination
17 minutes (plasma)
Excretion
Mainly via kidney
Formula
C26H40O5
Molar Mass
432.601
Onset of Action
3–4 hours
Duration of Action
≥ 24 hours
Volume of Distribution
C26H40O5

🤰 Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.